These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10936742)

  • 1. Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
    Gräser T; Müller A; Mellinger U; Mück AO; Lippert TH; Oettel M
    Maturitas; 2000 Jun; 35(3):253-61. PubMed ID: 10936742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol valerate/dienogest.
    Wellington K; Perry CM
    Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
    Gräser T; Koytchev R; Müller A; Oettel M
    Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
    Gräser T; Römer T; Wiedey KD; Janaud A
    Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
    von Schoultz B
    Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
    Saure A; Planellas J; Poulsen HK; Jaszczak P
    Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
    Jensen JT; Parke S; Mellinger U; Machlitt A; Fraser IS
    Obstet Gynecol; 2011 Apr; 117(4):777-787. PubMed ID: 21422847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B
    Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.
    Endrikat J; Lange E; Kunz M; Schmidt W; Graeser T
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):229-39. PubMed ID: 17763261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of estradiol valerate/dienogest.
    Teichmann A
    Climacteric; 2003 Aug; 6 Suppl 2():17-23. PubMed ID: 14669840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under.
    Jensen JT; Bitzer J; Nappi RE; Ahlers C; Bannemerschult R; Parke S
    Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):98-105. PubMed ID: 32162555
    [No Abstract]   [Full Text] [Related]  

  • 15. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.
    Varila E; Wahlström T; Rauramo I
    Fertil Steril; 2001 Nov; 76(5):969-73. PubMed ID: 11704119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM; Martell CW
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.
    Burch D; Bieshuevel E; Smith S; Fox H
    Maturitas; 2000 Feb; 34(2):155-60. PubMed ID: 10714910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
    Saletu B; Anderer P; Gruber D; Metka M; Huber J; Saletu-Zyhlarz GM
    Maturitas; 2002 Nov; 43(3):165-81. PubMed ID: 12443834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous combined hormone replacement therapy compared with tibolone.
    Al-Azzawi F; Wahab M; Habiba M; Akkad A; Mason T
    Obstet Gynecol; 1999 Feb; 93(2):258-64. PubMed ID: 9932566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.